Founding Date | 2012 |
Calcivis total Funding | $22.3 m |
Calcivis latest funding size | $5.48 m |
Time since last funding | a year ago |
Calcivis investors | Scottish Investment Bank, ArchAngels, Biomedical Catalyst Fund, Archangel Investors, EASME - EU Executive Agency for SMEs, Julz, Hedge Fund |
GBP | FY, 2015 | FY, 2016 | FY, 2018 |
---|---|---|---|
Revenue | 465.3k | 1.1m | 12.2k |
Cost of goods sold | 4.0k | ||
Gross profit | 8.1k | ||
Gross profit Margin, % | 67% | ||
Depreciation and amortization | 12.5k | 18.8k | 17.8k |
EBIT | (666.6k) | (1.3m) | (3.0m) |
EBIT margin, % | (143%) | (117%) | (24420%) |
Interest income | 1.3k | ||
Pre tax profit | (666.2k) | (1.3m) | (3.0m) |
Income tax expense | 6.4k | (277.3k) | |
Net Income | (666.2k) | (1.3m) | (2.7m) |
GBP | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|
Cash | 421.9k | 1.5m | 792.3k | 1.8m | 1.9m |
Accounts Receivable | 162.5k | ||||
Inventories | 3.4k | 159.7k | |||
Current Assets | 584.3k | 1.6m | 2.3m | 2.0m | 2.6m |
PP&E | 30.3k | 52.0k | 47.2k | 36.4k | 30.2k |
Total Assets | 889.9k | 1.9m | 2.5m | 2.2m | 2.7m |
Accounts Payable | 111.0k | 85.6k | 343.3k | 154.0k | 266.9k |
Current Liabilities | 111.0k | 157.6k | 1.1m | 261.7k | 354.1k |
Non-Current Liabilities | 6.6k | 377.6k | |||
Total Liabilities | 117.6k | 535.2k | 1.1m | 261.7k | 354.1k |
Common Stock | 10.0 | 13.0 | 16.0 | 20.0 | 26.0 |
Retained Earnings | (1.5m) | (2.1m) | (3.3m) | (5.0m) | (7.5m) |
Total Equity | 772.4k | 1.3m | 1.4m | 1.9m | 2.4m |
Financial Leverage | 1.2 x | 1.4 x | 1.8 x | 1.1 x | 1.1 x |
GBP | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|
Cash From Operating Activities | (55.5k) | (2.0m) | (1.2m) | (2.8m) |
Cash From Investing Activities | (33.8k) | (13.3k) | (8.9k) | (10.3k) |
Cash From Financing Activities | 1.2m | 1.2m | 2.2m | 3.0m |
Net Change in Cash | 1.1m | (752.5k) | 1.0m | 120.9k |
GBP | FY, 2014 |
---|---|
Financial Leverage | 1.2 x |